Rationale for the antihistamine for the treatment of chronic urticaria and allergic rhinitis
- Authors: Smolkin Y.S1,2
-
Affiliations:
- Institute of Professional Development
- Research and Clinical Center of Allergology and Immunology
- Issue: Vol 17, No 11 (2015)
- Pages: 82-86
- Section: Articles
- URL: https://bakhtiniada.ru/2075-1753/article/view/94449
- ID: 94449
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Yu. S Smolkin
Institute of Professional Development; Research and Clinical Center of Allergology and Immunology
Email: smolking@df.ru
д-р мед. наук, проф. каф. аллергологии и клинической иммунологии ФГБУ ДПО ИПК, глав. врач НККЦ аллергологии и иммунологии, вице-президент Ассоциации детских аллергологов и иммунологов России 125371, Russian Federation, Moscow, Volokolamskoe sh., d. 91
References
- Victor N, Windeler J, Hasford J et al. Empfehlungen zur Durchführung von Anwendungsbeobachtungen. Informatik Biometrie Epidemiologie Med Biologie 1997; 28: 247-52.
- Bundesinstitut für Arzneimittel und Medizinprodukt: Gemeinsame Empfehlungen des Bundesinstituts für Arzneimittel und Medizinprodukte und des Paul-Ehrlich-Instituts zur Planung, Durchführung und Auswertung von Anwendungsbeobachtungen Entwurfsfassung vom 9. Mai 2007.
- Augustin M, Ehrle S. Safety and efficacy of desloratadine in chronic idiopathic urticarial in clinical practice: an observational study of 9246 patients. JEADV 2009; 23: 292-9.
- Greaves M.W. Chronicurticaria. N Engl J Med 1995; 332: 1767-72.
- Zuberbier T, Bindslev-Jensen C, Canonica W et al. EAACI/GA2LEN/EDF guideline: defnition, classifcation and diagnosis of urticaria. Allergy 2006; 61: 316-20.
- Sabroe R.A, Greaves M.W. The pathogenesis of chronic idiopathic urticaria. Arch Dermatol 1997; 133: 1003-8.
- Berger W.E. The safety and efficacy of desloratadine for the management of allergic disease. Drug Saf 2005; 28: 1101-18.
- Kulthanan K, Jiamton S, Thumpimukvatana N, Pinkaew S. Chronic idiopathic urticaria: prevalence and clinical course. J Dermatol 2007; 34: 294-301.
- Gaig P, Olona M, Munoz Lejarazu D et al. Epidemiology of urticaria in Spain. J Invest Allergol Clin Immunol 2004; 14: 214-20.
- Vázquez Nava F, Almeida Arvizu V.M, Sánchez Nuncio H.R et al. [Prevalence and potential triggering factors of chronic urticaria and angioedema in an urban area of northeastern Mexico.] Rev Alerg Mex 2004; 51: 181-8.
- Zuberbier T, Maurer M. Urticaria: current opinions about etiology, diagnosis and therapy. Acta Derm Venereol 2007; 87: 196-205.
- Ozkan M, Ozkan M, Oflaz S.B et al. Psychiatric morbidity and quality of life in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2007; 99: 29- 33.
- Staubach P, Eckhardt-Henn A, Dechene M et al. Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol 2006; 154: 294-8.
- Weldon D.R. Quality of life in patients with urticaria. Allergy Asthma Proc 2006; 27: 96-9.
- Grob J.J, Gaudy-Marqueste C. Urticaria and quality of life. Clin Rev Allergy Immunol 2006; 30: 47-51.
- Grob J.J, Auquier P, Martin S et al. Development and validation of a quality of life measurement for chronic skin disorders in French: VQ-Dermato. The ReseaudEpidemiolo gie en Dermatologie. Dermatology 1999; 199: 213-22.
- Baiardini I, Pasquali M, Braido F et al. A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-Q2oL). Allergy 2005; 60: 1073-8.
- O'Donnell B.F, Lawlor F, Simpson J et al. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136: 197-201.
- Patrick D.L. Assessing health - related quality of life outcomes. In: Heithoff K.A, Lohr K.N, editors. Effectiveness and outcomes in health care: proceedings of an invitational conference by the Institute of Medicine. Washington, DC: National Academies Press, 1990; p. 137-51.
- Weldon D.R. Quality of life in patients with urticaria. Allergy Asthma Proc 2006; 27: 96-9.
- Baiardini I, Giardini A, Pasquali M et al. Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. Allergy 2003; 58: 621-3.
- Grob J.J, Auquier P, Dreyfus I, Ortonne J-P. How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life. Allergy 2009; 64: 605-12.
- Lennox R.D, Leahy M.J. Validation of the Dermatology Life Quality Index as an outcome measure for urticarial - related quality of life. Ann Allergy Asthma Immunol 2004; 93: 142-6.
- Grob J.J, Revuz J, Ortonne J.P, Auquier P, Lorette G. Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life. Br J Dermatol 2005; 152: 289-95.
- Simons F.E.R, Silver N.A, Gu X, Simons K.J. Skin concentrations of H1-receptor antagonists. J Allergy Clin Immunol 2001; 107: 526-30.
- Gillard M, Strolin Benedetti M, Chatelain P, Baltes E. Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines. Inflamm Res 2005; 54: 367-9.
- Spector S.L, Shikiar R, Harding G et al. The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria. Cutis 2007; 79: 157-62.
- Holmberg K, Tonnel A-B, Dreyfus I et al. Desloratadine relieves nasal congestion and improves quality - of - life in persistent allergic rhinitis. Allergy 2009; 64: 1663-70.
- Jaeschke R, Singer J, Guyatt G.H. Measurements of health status: ascertaining the minimal clinically important difference. Controlled Clin Trials 1989; 10: 407- 15.
- Horak F, Stubner U.P, Zieglmayer R et al. Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass polleninduced allergic rhinitis in an allergen - exposure unit. J Allergy Clin Immunol 2002; 109: 956-61.
- Bout J, Ksquehaltaev N, Cruz A.A et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen. Allergy 2008; 63 (Suppl. 86): 8-160.
- Ciprandi G, Cirillo I, Vizzaccaro A et al. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study. Int Immunopharmacol 2005; 5: 1800-8.
- Greiff L, Persson C.G, Andersson M. Desloratadine reduces allergen challenge - induced mucinous secretion and plasma exudation in allergic rhinitis. Ann Allergy Asthma Immunol 2002; 89: 413-8.
- Horak F, Stubner U.P, Zieglmayer R, Harris A.G. Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure. Allergy 2003; 58: 481-5.
- Lee D.K, Gardiner M, Haggart K et al. Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis. Clin Exp Allergy 2004; 34: 650-3.
- Lam H.C, Tong M.C, van Hasselt C.A. Rhinitis symptoms and quality of life in patients with chronic perennial rhinitis treated with desloratadine. Laryngol Otol 2007; 121: 1151-5.
- Berger W.E, Lumry W.R, Meltzer E.O, Pearlman D.S. Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis. Allergy Asthma Proc 2006; 27: 214-23.
- Meltzer E.O, Jalowayski A.A, Vogt K et al. Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: results of a single - center, placebo - controlled trial. Ann Allergy Asthma Immunol 2006; 96: 363-8.
- Nayak A.S, Schenkel E. Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis. Allergy 2001; 56: 1077-80.
- Bachert C, Bousquet J, Canonica G.W et al. Levocetirizine improves quality of life and reduces costs in long - term management of persistent allergic rhinitis. J Allergy Clin Immunol 2004; 114: 838-44.
- Bousquet J, van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108 (Suppl. 5): S147-S334.
- Bousquet J, Khaltaev N, Cruz A.A et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63 (Suppl. 86): 8-160.
- Bauchau V, Durham S.R. Epidemiological characterization of the intermittent and persistent types of allergic rhinitis. Allergy 2005; 60: 350-3.
- Bousquet J, Annesi-Maesano I, Carat F et al. Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group. Clin Exp Allergy 2005; 35: 728-32.
Supplementary files
